Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Boehringer Ingelheim Vietnam Honored As Top Employer For The Fourth Consecutive Year 2023-01-18 09:00
Telix Reports Fourth Quarter 2022 Financial Results 2023-01-18 08:50
Transcenta to Present "Trial in Progress" at ASCO-GI 2023 for TST001 (Osemitamab) Combination with Nivolumab, with or without Chemotherapy in Advanced G/GEJ Cancer 2023-01-18 08:00
IASO Bio Raises Nearly $75 Million in Series C1 Funding 2023-01-18 08:00
Everest Medicines Announces Top-line Data from Phase I Study of EVER206 on Healthy Subjects in China 2023-01-18 07:30
Abbisko Therapeutics Obtains Approval from The China NMPA to Conduct a Phase II Clinical Study of Pimicotinib (ABSK021) in cGVHD 2023-01-18 07:00
Asieris Appoints Dr. Linda Wu as Chief Development Officer 2023-01-18 07:00
Tanso Biosciences Expands Its Line-up with 250 Mouse GPCRs 2023-01-18 00:00
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC 2023-01-17 19:42
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer 2023-01-17 10:00
Ascletis Announces Entering into a Supply Agreement of Ritonavir Tablets with Simcere 2023-01-17 08:29
AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China 2023-01-17 08:00
FDA Accepts GMP Plasmid DMF of OBiO Technology 2023-01-17 08:00
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China 2023-01-16 18:00
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 17:00
JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA 2023-01-12 13:02
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 06:00
CGTN: TCM continues to play significant role in treating COVID-19 2023-01-11 23:09
Bio4t2 announces first patient infused with CAR-T targeting solid tumors 2023-01-11 09:00
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval 2023-01-11 09:00
1 91 92 93 94 95 377